期刊文献+

厄贝沙坦治疗慢性肾功能不全的疗效与患者尿NO水平的相关研究 被引量:2

Study on therapeutic effect of irbesartan on patients with chronic renal insufficiency and its correlation with urinary NO levels
下载PDF
导出
摘要 目的:探讨厄贝沙坦治疗慢性肾功能不全的疗效及对一氧化氮的影响。方法:用比色法检测厄贝沙坦治疗前后尿一氧化氮水平。结果:慢性肾功能不全患者尿一氧化氮浓度明显下降,与尿钠、尿量呈明显的正相关,研究组的尿一氧化氮水平在厄贝沙坦治疗4周后有明显的增加。结论:尿一氧化氮水平与肾脏的功能有一定的相关性,一氧化氮在慢性肾功能不全水钠平衡的调节中发挥了重要的作用,厄贝沙坦可促进慢性肾功能不全一氧化氮合成,对肾脏有保护作用。 Objective:To investigate the effect of irbesartan on chronic renal insufficiency and its effect on nitric oxide.Methods:Urine and nitric oxide levels were measured before and after irbesartan treatment by spectrophotometry.Results:The levels of urinary NO in patients with chronic renal insufficiency decreased significantly,and there was a significant positive correlation between urinary sodium and urinary output.The urinary nitric oxide was significantly increased after irbesartan treatment for 4 weeks.Conclusions:The function of the kidney is related to the level of urinary nitric oxide.Nitric oxide plays an important role in the regulation of water sodium balance in chronic renal insufficiency.Irbesartan can promote the synthesis of chronic renal insufficiency and nitric oxide,which has a protective effect on the kidney.
作者 闫尚和 刘玉芝 丁银霞 王力刚 Yan Shanghe;Liu Yuzhi;Ding Yinxia;Wang Ligan(Huimin County People's Hospital of Shandong Provinee 251700;Binzhou Youfu Hospital of Shandong Provinee 2566002)
出处 《中国社区医师》 2018年第19期73-74,共2页 Chinese Community Doctors
关键词 厄贝沙坦 慢性肾功能不全 一氧化氮 Irbesartan Chronic renal insufficiency Nitric oxide
  • 相关文献

二级参考文献18

  • 1Raju N,Sobieraj Teague M, H irsh J, et al. Effect of aspi- rin on mortality in the primary prevention of cardiovascu- lar diease[J]. Am J Med,2011,124(7) :621-629.
  • 2Malekzadeh F, Marshall T, Pourshams A, et al. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (polypill) on cardiovascular risk factors [J]. Int J Clin Pract, 2010,64 (9) : 1220-1227.
  • 3Dao H H, Essalihi R, Bouvet C, et al. Evolution and modu- lation of age-related medial elastocalcinosis, impact on large artery stiffness and isolated systolic hypertension [J]. Cardiovasc Res, 2005,66 (2) : 307-317.
  • 4Conlin PR, Spence JD, Williams B, et al. Angiotensin l] antagonists for hypertension,are there difference in effi- cacy[J]. Am J Hypertens, 2000,13 (4 Pt 1) : 418-426.
  • 5Petrella R, Michailidis P. Retrospective analysis of real- world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management[J]. Clin Ther,2011,33 (9), 1190-1203.
  • 6Schmieder RE, Schwertfeger M, Bramlage P. Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice [J ]. Vase Health Risk Manag, 2009 (5) : 991-1000.
  • 7刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6936
  • 8王瑞英,王蕊,郭琼,杨娴.老年高血压伴餐后高血糖患者炎性因子变化及阿卡波糖的干预[J].中华老年心脑血管病杂志,2012,14(3):274-276. 被引量:7
  • 9刘忠玉,李辰,黄榕,周亚丽,张艳君,赵宗峰.超敏C反应蛋白与维吾尔族老年单纯收缩期高血压患者血管内皮功能的相关性[J].安徽医科大学学报,2014,49(3):338-342. 被引量:7
  • 10利冬梅.高血压患者血压变异性与颈动脉硬化斑块的关系分析[J].广西医学,2014,36(6):828-830. 被引量:12

共引文献62

同被引文献19

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部